Next Article in Journal
Parabens as Agents for Improving Crocetin Esters’ Shelf-Life in Aqueous Saffron Extracts
Previous Article in Journal
Phosphotungstic Acid: An Efficient, Cost-effective and Recyclable Catalyst for the Synthesis of Polysubstituted Quinolines
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 14
Issue 3
10.3390/molecules14031145
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Ring-substituted 4-Hydroxy-1H-quinolin-2-ones: Preparation and Biological Activity

by
Josef Jampilek
1, 2,*,
Robert Musiol
3,
Matus Pesko
4,
Katarina Kralova
4,
Marcela Vejsova
5,
James Carroll
6,
Aidan Coffey
6,
Jacek Finster
3,
Dominik Tabak
3,
Halina Niedbala
3,
Violetta Kozik
3,
Jaroslaw Polanski
3,
Jozef Csollei
2 and
Jiri Dohnal
1, 2
1
Zentiva k.s., U kabelovny 130, 102 37 Prague 10, Czech Republic
2
Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1/3, 61242 Brno, Czech Republic
3
Institute of Chemistry, University of Silesia, Szkolna 9, 40007 Katowice, Poland
4
Institute of Chemistry, Faculty of Natural Sciences, Comenius University, Mlynska dolina Ch-2, 84215 Bratislava, Slovakia
5
Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
6
Department of Biological Sciences, Cork Institute of Technology, Bishopstown, Cork, Ireland
*
Author to whom correspondence should be addressed.
Molecules 2009, 14(3), 1145-1159; https://doi.org/10.3390/molecules14031145
Submission received: 4 February 2009 / Revised: 3 March 2009 / Accepted: 11 March 2009 / Published: 13 March 2009
Browse Figures
Versions Notes

Abstract

:
In the study, a series of twelve ring-substituted 4-hydroxy-1H-quinolin-2-one derivatives were prepared. The procedures for synthesis of the compounds are presented. The compounds were analyzed using RP-HPLC to determine lipophilicity and tested for their photosynthesis-inhibiting activity using spinach (Spinacia oleracea L.) chloroplasts. All the synthesized compounds were also evaluated for antifungal activity using in vitro screening with eight fungal strains. For all the compounds, the relationships between the lipophilicity and the chemical structure of the studied compounds are discussed, as well as their structure-activity relationships (SAR).

1. Introduction

The quinoline scaffold is present in many classes of biologically-active compounds [1]. A series of compounds derived from 8-hydroxyquinoline and styrylquinoline derivatives were recently synthesized as potential HIV-1 integrase inhibitors [2,3]. These compounds show a significant similarity to some novel antifungal agents, namely homoallylamines, and therefore possess potential antifungal activity [4]. Our previous study dealing with 8-hydroxyquinoline and styrylquinoline derivatives showed that they could also possess a strong antifungal activity [5,6,7]. According to the results reported recently, some new hydroxyquinoline derivatives also possess interesting herbicidal activities [6,8,9,10,11,12,13]. Some investigated compounds also showed antineoplastic activity [14].
Photosystem II (PS II) is a multisubunit membrane protein complex, which uses light energy to oxidize water and reduce plastoquinone. Binding of herbicides to photosystem II inhibits the electron transfer from QA to QB due to competition of herbicides with plastoquinone bound at the QB site. Thus, the QB quinone-binding site of photosystem II is an important target for herbicides, including herbicides based on phenylurea moieties. It was found that a tail can be attached to the para position of phenylurea-type herbicides without any loss of binding, provided that the tail is hydrophobic. This indicates that the herbicides must be oriented in the QB site so that these positions point toward the natural isoprenyl tail-binding pocket that extends out of the QB site. In turn, the requirement that the tail must extend out of the QB site constrains the size of the other herbicide substituents in the pocket [15]. In addition to phenylurea-type herbicides, various other compounds possessing an amide -NHCO- moiety were also found to inhibit the photosynthetic electron transport [16,17,18,19,20,21]. Better understanding of these SAR relationships are not only important for the design of modern agricultural agents, but can also provide remarkable insights into the photosynthetic mechanisms of green cells.
Over the last three decades there has been a dramatic increase in the incidence of fungal infections, and the discovery of new drugs for the treatment of systemic mycoses is a major challenge in infectious disease research. There is an intensified need for new antifungal remedies with novel modes of action due to the rapid growth of the immunocompromised patient population, the development of resistance to the present azole therapies, and high toxicity of polyenes [22,23,24].
Compounds bearing a quinoline moiety are well known due to their broad biological activity [6]. In particular, hydroxyquinoline and its derivatives were introduced as antifungal agents in clinical practice and the novel compounds of this type are still investigated [25,26]. This paper deals with synthesis, herbicidal and antifungal activity of ring-substituted 4-hydroxy-1H-quinolin-2-one derivatives. All the compounds were tested for their photosynthesis-inhibiting activity (the inhibition of photosynthetic electron transport in spinach chloroplasts (Spinacia oleracea L.). Primary in vitro screening of all synthesized compounds was evaluated against eight fungal strains by means of the broth microdilution test in RPMI 1640 medium [27]. Lipophilicity (log k) of the compounds was determined using RP-HPLC. The procedure was performed under isocratic conditions with methanol as an organic modifier in the mobile phase using end-capped non-polar C18 stationary RP column. The structure-activity relationships of the compounds are also discussed.

2. Results and Discussion

2.1. Chemistry

In most of the synthesis protocols, aniline derivatives were used as the starting materials due to their convenient availability from chemical providers. Microwave assisted synthesis with malonic acid or its esters, was used to make compounds 1-4. Further nitration and reduction according to established procedures were used to make compounds 5 and 6. Acylation of 6 with cinnamoyl chloride provided compound 7. Diazo derivative 8 was made by means of a two-step synthesis from 4-aminobenzoic acid and diethyl malonate and gave 4-hydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic acid, which was coupled with the freshly prepared diazo salt derived from 4-nitro-2,5-dichloroaniline. Quinolines functionalized with carboxylic acid groups at C(3) 9-12 were obtained in neat microwave assisted synthesis in moderate or good yield. Synthesis of all the above compounds is depicted in Scheme 1.
Molecules 14 01145 g003 550
Scheme 1. General preparation of quinoline derivatives 1-12: (a) PPA, microwave irradiation; (b) HNO3; (c) Sn, HCl; (d) cinnamoyl chloride; (e) (2,5-dichloro-4-nitrophenyl)diazonium chloride; (f) microwave irradiation; (g) hydrolysis.
Scheme 1. General preparation of quinoline derivatives 1-12: (a) PPA, microwave irradiation; (b) HNO3; (c) Sn, HCl; (d) cinnamoyl chloride; (e) (2,5-dichloro-4-nitrophenyl)diazonium chloride; (f) microwave irradiation; (g) hydrolysis.
Molecules 14 01145 g003

2.2. Lipophilicity

Hydrophobicities (log P/Clog P values) of the compounds 1-12 were calculated using two commercially available programs and also measured by means of the reversed phase high performance liquid chromatography (RP-HPLC) method for lipophilicity measurement. The procedure was performed under isocratic conditions with methanol as an organic modifier in the mobile phase using an end-capped non-polar C18 stationary RP column. The capacity factors k were determined and subsequent log k values were calculated.
The results are summarized in Table 1 and illustrated in Figure 1. The results obtained with all the compounds show that the experimentally-determined lipophilicities (log k values) are lower than those indicated by the calculated log P/Clog P, as shown in Figure 1, indicating relatively poor correlation between the experimentally-determined log k values and the calculated values. As expected, compound 8 showed the highest lipophilicity, while compound 3 possessed the lowest hydrophobicity, which was unexpected. Compound 7 showed less hydrophobicity contrary to all the results of the lipophilicity calculated by software. Comparing the lipophilicity data log k of both position analogues 3 and 4, it can be stated that the 7-hydroxy derivative 4 possessed higher hydrophobicity than 5-hydroxy analogue 3. The salicylic acid derivative 12 showed higher lipophilicity than benzoic derivative 11. These facts are caused by intramolecular interactions [28].
Molecules 14 01145 g001 550
Figure 1. Comparison of the computed log P/Clog P values using the two programs with the calculated log k values. The discussed compounds 1-12 are ordered according to the log k values increase.
Figure 1. Comparison of the computed log P/Clog P values using the two programs with the calculated log k values. The discussed compounds 1-12 are ordered according to the log k values increase.
Molecules 14 01145 g001
Table
Table 1. Comparison of the calculated lipophilicities (log P/Clog P) with the determined log k values.
Table 1. Comparison of the calculated lipophilicities (log P/Clog P) with the determined log k values.
Molecules 14 01145 i001
Comp.R1R2log klog P/Clog P
ChemOffice		log P
ACD/LogP
1HH0.06640.49 / 1.2161.10 ± 0.75
26-CH3H0.33070.97 / 1.7151.56 ± 0.75
36-COOH-5-OHH0.0002-0.34 / 1.2611.47 ± 0.75
46-COOH-7-OHH0.0080-0.34 / 1.0702.22 ± 0.75
5H-NO20.40521.39 / 0.836-0.14 ± 1.00
6H-NH20.0004-1.06 / 0.719-0.32 ± 1.00
7H Molecules 14 01145 i0020.01281.11 / 2.8482.45 ± 1.00
86-COOH Molecules 14 01145 i0030.63945.22 / 3.8404.41 ± 1.00
9H-COOC2H50.45950.51 / 1.6941.17 ± 0.75
10H-COOH0.0118-0.09 / 1.4091.71 ± 0.35
116-COOH Molecules 14 01145 i0040.00810.27 / 2.4451.67 ± 1.00
126-COOH-5-OH Molecules 14 01145 i0050.0093-0.51 / 2.5432.20 ± 1.00

2.3. Oxygen evolution rate inhibition in spinach chloroplasts

All compounds were evaluated for their in vitro herbicidal efficiency. The results are listed in Table 2. Quinoline derivatives 1-12 showed a wide range of activity related to inhibition of oxygen evolution rate (OER) in spinach chloroplasts. Two compounds showed interesting IC50 (half maximal inhibitory concentration) values: 126 µmol/L (8) and 157 µmol/L (2); nevertheless the studied activity of all the other compounds was very low.
Due to the moderate and/or low activity of compounds 1-12, it is difficult to determine simple structure-activity relationships. However some interesting observations can be made: in the case of compound 1, an unsubstituted structure did not have any effect on OER in chloroplasts. The remaining compounds could be divided into two groups according to their chemical structure. Group 1 includes compounds 2-4, 8, 11 and 12, and Group 2 compounds 5-7, 9 and 10.
Group 1 showed higher biological activity than Group 2. The activity related to OER inhibition seems to be positively influenced by substitution of ring B: especially the C(6) position (see compounds 2-4, 11, 12). Comparison of the OER-inhibiting activities of compounds 2-4, 8, 11 and 12 also indicated that the lipophilicity increase is connected with the quasi-parabolic increase of biological activity (Figure 2).
Table
Table 2. IC50 values related to OER inhibition in spinach chloroplasts in comparison with 3-(3,4-dichlorophenyl)-1,1-dimethylurea (DCMU) standard and in vitro antifungal activity (IC80) of compounds 1-12 compared with fluconazole (FLU) standard.
Table 2. IC50 values related to OER inhibition in spinach chloroplasts in comparison with 3-(3,4-dichlorophenyl)-1,1-dimethylurea (DCMU) standard and in vitro antifungal activity (IC80) of compounds 1-12 compared with fluconazole (FLU) standard.
Comp.OER inhibition MIC/IC80 [µmol/L]
CACTCKCGTBAFACTM
IC50 [μmol/L] 24h24h24h24h24h24h24h72h
48h48h48h48h48h48h48h120h
1925>500>500>500>500>500>500>500>500
>500>500>500>500>500>500>500>500
2157>500>500>500>500>500>500>500>500
>500>500>500>500>500>500>500>500
3346125500>500250250>500>500>500
125>500>500250>500>500>500>500
453815.62500>50062.5062.50500>500>500
62.50>500>500250>500>500>500>500
5510>500>500>500>500>500>500>500>500
>500>500>500>500>500>500>500>500
6775>500>500>500>500>500>500>500>500
>500>500>500>500>500>500>500>500
7916>125>125>125>125>125>125>125>125
>125>125>125>125>125>125>125>125
812631.2525025025025012562.5062.50
125>250250>250>250250250125
9494>500>500>500>500>500>500>500>500
>500>500>500>500>500>500>500>500
10567>500>500>500>500>500>500>500>500
>500>500>500>500>500>500>500>500
11380>500>500>500>500>500>500>500>500
>500>500>500>500>500>500>500>500
1232162.50500>500125125500500500
125>500>500250>500>500>500>500
DCMU1.9--------
FLU-0.060.123.910.980.24>125>1251.95
0.12>12515.623.910.48>125>1253.91
It is noteworthy that there are great differences in OER inhibition levels caused by positional isomers 3 (6-COOH-5-OH) and 4 (6-COOH-7-OH). Introducing a further phenolic moiety in compound 12 (salicylic derivative) positively influenced OER inhibition. The higher inhibitory effect of compound 8 compared with compound 2 may have resulted from higher lipophilicity (easier penetration of the compound through cell walls) and/or redox properties of the nitro moiety of the 2,5-dichloro-4-nitrophenyldiazenyl substituent.
Molecules 14 01145 g002 550
Figure 2. Relationships between the OER inhibition log (1/IC50) [mmol/L] in spinach chloroplasts and lipophilicity (log k) of the studied compounds 1-12.
Figure 2. Relationships between the OER inhibition log (1/IC50) [mmol/L] in spinach chloroplasts and lipophilicity (log k) of the studied compounds 1-12.
Molecules 14 01145 g002
Generally, Group 2 compounds only caused slight inhibition of OER; nevertheless compounds 5 and 9 were approximately twice as effective as compound 1. All these compounds possess the substituted position C(3) of ring A, which caused the decrease in OER inhibition compared with Group 1 compounds. The most active compound from Group 2 was the ester 9.

2.4. In vitro antifungal susceptibility testing

All the compounds were tested for their in vitro antifungal activity. Compounds 1-3, 5-7, 9-11 did not show any activity and compounds 4, 8 and 12 showed only a moderate activity, especially against Candida albicans ATCC 44859. Compound 4 showed medium activity against Candida glabrata 20/I, and compound 8 against Trichophyton mentagrophytes 445. The activities of the compounds are shown in Table 2.
Generally, it can be stated that in vitro antifungal activity depends on heteroaromatic ring A. Hydrogenation of ring A and introduction of keto group resulted in the loss of the antifungal effect compared with hydroxyquinoline derivatives [6,7]. Substitution of the C(3) position by various moieties did not have a significant influence on the activity. Nevertheless salicylic acid derivative 12 showed a higher activity compared with benzoic derivative 11, probably due to the substitution of the C(3)´ position by phenolic moiety.
Unsubstituted ring B or C(6) substitution by a methyl moiety did not results in any activity. Substitution of phenyl ring B by 6-COOH (compounds 3, 4, 8 and 11, 12) caused the activity to increase. Position of the phenolic moiety seems to be a very important parameter for antifungal activity. While a 6-COOH-5-OH substitution pattern (compound 3) did not show any activity increase, introduction of 6-COOH along with a 7-OH moiety (compound 4) increased the activity significantly. The antifungal activity of compounds 8 and 12 was connected with 2,4-dichloro-4-nitrophenyldiazenyl and 3-(4-carboxy-3-hydroxyphenylcarbamoyl) substituents, respectively. According to the results, it can be assumed that lipophilicity is only of secondary importance for antifungal activity.

3. Conclusions

A series of twelve ring-substituted 4-hydroxy-1H-quinolin-2-one derivatives were prepared and characterized. All the prepared quinoline derivatives were analyzed using a RP-HPLC method for the lipophilicity measurement and their lipophilicity was determined. The prepared compounds were tested for their photosynthesis-inhibiting activity (the inhibition of photosynthetic electron transport in spinach chloroplasts (Spinacia oleracea L.) and for their antifungal activity. (E)-3-[(2,5-Dichloro-4-nitrophenyl)diazenyl]-4-hydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic acid (8) showed the highest OER inhibition activity and 4,7-dihydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic acid (4) and compound 8 possessed the highest in vitro antifungal activity within the series.

4. Experimental

4.1. General

All reagents were purchased from Aldrich. Kieselgel 60, 0.040-0.063 mm (Merck, Darmstadt, Germany) was used for column chromatography. TLC experiments were performed on alumina-backed silica gel 40 F254 plates (Merck, Darmstadt, Germany). The plates were illuminated under UV (254 nm) and evaluated in iodine vapour. The melting points were determined on Boetius PHMK 05 (VEB Kombinat Nagema, Radebeul, Germany) and are uncorrected. Elemental analyses were carried out on an automatic Perkin-Elmer 240 microanalyser (Boston, USA). The purity of the final compounds was checked by the HPLC separation module Waters Alliance 2695 XE (Waters Corp., Milford, MA, U.S.A.). The detection wavelength 210 nm was chosen. The peaks in the chromatogram of the solvent (blank) were deducted from the peaks in the chromatogram of the sample solution. The purity of individual compounds was determined from the area peaks in the chromatogram of the sample solution. UV spectra (λ, nm) were determined on a Waters Photodiode Array Detector 2996 (Waters Corp., Milford, MA, U.S.A.) in ca 6×10-4 mol methanolic solution and log ε (the logarithm of molar absorption coefficient ε) was calculated for the absolute maximum λmax of individual target compounds. Infrared spectra were recorded in a Smart MIRacle™ ATR ZnSe for Nicolet™ 6700 FT-IR Spectrometer (Thermo Scientific, U.S.A.). Spectra are corrigated. All 1H NMR spectra were recorded on a Bruker AM-500 (499.95 MHz for 1H), Bruker BioSpin Corp., Germany. Chemicals shifts are reported in ppm (δ) to internal Si(CH3)4, when diffused easily exchangeable signals are omitted.
4-Hydroxyquinolin-2(1H)-one (1). Preparation of PPA: P2O5 (287.9 g) was added to 85% phosphoric acid (200 g, 118.4 mL) under stirring and microwave heating. The mixture was then heated for 15 min. Aniline (7 mL, 5 mmol) and malonic acid (5.2 g, 5 mmol) were thoroughly mixed with 20 g PPA and heated under stirring in microwave reactor at 400 W during 2×20 min with 5 min interval. The temperature reached 210 °C. Then the mixture was poured into crushed ice and the beige solid was filtered and purified by extraction with EtOH and a white crystalline compound was obtained [29]. Yield 35%; Mp 340 °C; HPLC purity 97.12%; UV (nm), λmax/log ε: 231.3/3.51; IR (cm-1): 3618, 1180 (OH), 3043 (=CH-), 1670 (lactam), 1650 (C=O), 1593 (Ph), 1522 (NH).
4-Hydroxy-6-methylquinolin-2(1H)-one (2). The product was obtained according to the previously described procedure [30,31] as a light brown crystalline compound. Yield 35%; Mp 320 °C; HPLC purity 97.72%; UV (nm), λmax/log ε: 232.4/3.55; IR (cm-1): 3618, 1180 (OH), 3044 (=CH-), 2965, 1379 (CH3), 1668 (lactam), 1652 (C=O), 1592 (Ph), 1522 (NH).
4,5-Dihydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic acid (3). Naphthalene (15.4 g, 0.12 mol) and malonic acid (18.7 g, 0.18 mol) were melted with stirring under temperature control (<150 °C) to avoid decarboxylation of the acid. POCl3 (32.9 g, 0.36 mol) was then added dropwise over 30 min and p-aminosalicylic acid (15.3 g, 0.1 mol) was then added. The resulting mixture was heated for 30 min and allowed to cool. Water (100 mL) was added to the warm mixture and the solution was made alkaline to pH 9 with 20% NaOH. After cooling on ice precipitated naphthalene, it was filtered and the filtrate was acidified to pH 2. The product was filtered again and crystallized from acetic acid as a bright yellow crystalline compound. Yield 36%; Mp 250 °C; Anal. calc. for C10H7NO5 (221.16): C 54.31%, H 3.19%; found: C 54.51%, H 4.11%; HPLC purity 98.74%; UV (nm), λmax/log ε: 244.2/3.54; IR (cm-1): 3620, 1180 (OH), 3045 (=CH-), 2950, 1690 (acid), 1672 (lactam), 1650 (C=O), 1598 (Ph), 1523 (NH), 1329, 1198 (OHphenol); 1H-NMR (DMSO-d6) δ: 5.65 (s, 1H), 6.60 (d, J=8.3 Hz, 1H), 7.80 (d, J=8.3 Hz, 1H), 11.3 (bs, 1H), 12.20 (bs, 1H).
4,7-Dihydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic acid (4). The product was obtained as an isomer of 3 during its synthesis. Isolated by fractional crystalization as a white crystalline compound. Yield 36%; Mp 250 °C; Anal. calc. for C10H7NO5 (221.16): C 54.31%, H 3.19%; found: C 54.09%, H 3.52%; HPLC purity 98.51%; UV (nm), λmax/log ε: 243.0/3.54; IR (cm-1): 3618, 1181 (OH), 3043 (=CH-), 2948, 1693 (acid), 1670 (lactam), 1651 (C=O), 1599 (Ph), 1521 (NH), 1328, 1200 (OHphenol); 1H-NMR (DMSO-d6) δ: 5.60 (s, 1H), 6.67 (s, 1H), 8.25 (s, 1H).
4-Hydroxy-3-nitroquinolin-2(1H)-one (5). The product was obtained according to the described nitration procedure [32] as a yellow crystalline compound. Yield 71%; Mp 252-255 °C; HPLC purity 99.72%; UV (nm), λmax/log ε: 336.8/3.57; IR (cm-1): 3620, 1181 (OH), 1712 (C=O), 1682 (lactam), 1622 (C=Ccycle), 1595 (Ph), 1547 (NO2), 1525 (NH).
3-Amino-4-hydroxyquinolin-2(1H)-one (6). Compound 6 (2.0 g, 0.0097 mol) and tin powder (3.8 g, 0.032 mol) were stirred with 36% HCl (8.1 mL). The mixture was warmed at 80-90 °C for 30 min. The brown solution was cooled to room temperature and filtered. The filtrate was alkalized with NH3(aq) and warmed for 20 min. Then Celite (1.3 g) was added and filtered. The solid was washed thoroughly with hot water (80 °C). The combined filtrates were concentrated and acidified. After cooling a white crystalline compound was obtained. Yield 85%; Mp 300 °C [33]; HPLC purity 91.99%; UV (nm), λmax/log ε: 232.8/3.53; IR (cm-1): 3620, 1181 (OH), 3312, 1618 (NH2), 1670 (lactam), 1650 (C=O), 1625 (C=Ccycle), 1598 (Ph), 1523 (NH).
(2E)-N-(4-Hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)-3-phenylprop-2-enamide (7). Compound 7 (0.018 g, 0.001 mol) was mixed with water (5 mL), Et2O (5 mL) and sodium bicarbonate (0.3 g). The resulted mixture was stirred in an ice bath (-3 °C) and 10 mL of Et2O solution of cinamoyl chloride (0.017 g, 0.001 mol) was added slowly. The resulting mixture was stirred at room temperature for 2 days, cooled in fridge and filtered. Et2O was added to the solid and dried. A white crystalline compound was obtained. Yield 50%; Mp 145 °C; Anal. calc. for C18H14N2O3+H2O (324.33): C 66.66%, H 4.97%; found: C 66.54%, H 5.27%; HPLC purity 99.79%; UV (nm), λmax/log ε: 263.1/3.51; IR (cm-1): 3620, 1180 (OH), 3035 (CHarom), 1670 (lactam), 1650 (C=O), 1648 (amide), 1628 (C=Ccycle), 1618, 974 (C=C), 1599 (Ph), 1525 (NH); 1H-NMR (DMSO-d6) δ: 3.30 (s, 1H), 6.50 (d, J=16.2 Hz, 2H), 7.10 (s, 1H), 7.38 (m, 9H), 7.5 (s, 1H).
(E)-3-[(2,5-Dichloro-4-nitrophenyl)diazenyl]-4-hydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic acid (8). 4-Hydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic acid was obtained as compound 3 from 4-aminobenzoic acid and used without thorough purification in further synthesis as follows. IR (cm-1): 3618, 1179 (OH), 3043 (=CH-), 2948, 1686 (acid), 1677 (lactam), 1650 (C=O), 1599 (Ph), 1523 (NH); 1H-NMR (DMSO-d6) δ: 7.7 (s, 1H), 7.9 (m, 3H), 10.43 (s, 1H), 10.47 (s, 1H), 12.7 (s, 1H). 2,5-Dichloro-4-nitroaniline (0.92 g) was dissolved in 2:1 Et2O/EtOH , then 15% HCl (0.91 mL) was added to this solution and the mixture was cooled to 5 °C. NaNO2 (0.4 g, 5.7 mmol) and 4-hydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic acid (1.0 g, 5.7 mmol) was added slowly under the temperature of 5 °C and pH<7 (15% HCl). The resulting mixture was left in ice overnight. The precipitated solid was then filtered and crystallized from Et2O/EtOH. A reddish crystalline compound was obtained. Yield 64%; Mp 340 °C; Anal. calc. for C16H8Cl2N4O6 (423.16): C 45.41%, H 1.91%; found: C 45.26%, H 2.24%; HPLC purity 96.39%; UV (nm), λmax/log ε: 271.4/3.61; IR (cm-1): 3616, 1180 (OH), 3030 (CHarom), 2950, 1680 (acid), 1670 (lactam), 1655 (C=O), 1630 (C=Ccycle), 1614 (N=N), 1598 (Ph), 1543 (NO2), 1520 (NH); 1H-NMR (DMSO-d6) δ: 5.70 (s, 1H), 7.10-7.60 (m, 3H), 11.10 (s, 1H), 11.30 (s, 1H).
Ethyl 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylate (9). Aniline (0.46 mL, 0.005 mol) and triethyl methanetricarboxylate (2.12 mL, 0.01 mol) were heated in microwave reactor for 8 min at 60% power level. The mixture was then cooled to room temperature and 7 mL of Et2O was added. The crude product was crystallized from MeOH. A white crystalline compound was obtained. Yield 50%; Mp 116-120 °C; Anal. calc. for C12H11NO4 (233.22): C 61.80%, H 4.75%; found: C 61.65%, H 4.39%; HPLC purity 95.01%; UV (nm), λmax/log ε: 244.2/3.59; IR (cm-1): 3620, 1180 (OH), 2958 (CH3), 2925 (CH2), 1680 (lactam), 1638 (C=O), 1630 (C=Ccycle), 1598 (Ph), 1520 (NH), 1191 (C=Oester); 1H-NMR (DMSO-d6) δ: 1.19 (t, 3H), 4.17 (q, 2H), 4.70 (s, 1H), 7.09 (t, 2H), 7.32 (t, 1H), 7.52 (d, J=8.5 Hz, 1H), 10.30 (t, 1H).
4-Hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid (10). The product was obtained according to the described procedure [34,35] as a white crystalline compound. Yield 99%; Mp 225 °C; HPLC purity 99.51%; UV (nm), λmax/log ε: 250.1/3.52; IR (cm-1): 3621, 1182 (OH), 2965, 1670 (acid), 1679 (lactam), 1646 (C=O), 1629 (C=Ccycle), 1599 (Ph), 1525 (NH).
3-(4-Carboxyphenylcarbamoyl)-4-hydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic acid (11). 4-Aminobenzoic acid (0.7 g, 0.005 mol) was mixed with triethyl methanetricarboxylate (2.12 mL, 0.01 mol) and heated in microwave reactor at 50% of power during 15 min and 3 min at 90%. The temperature reached 231 °C during heating. Et2O was added to the cooled mixture and the precipitate was washed with hot (55 °C) MeOH to obtain the pure product as a yellow crystalline compound. Yield 62%; Mp 340-350 °C; Anal. calc. for C18H12N2O7 (368.29): C 58.70%, H 3.28%; found: C 58.09%, H 3.54%; HPLC purity 97.52%; UV (nm), λmax/log ε: 251.3/3.53; IR (cm-1): 3621, 1180 (OH), 3034 (CHarom), 2970, 1689 (acid), 1680 (lactam), 1642 (C=O), 1635 (C=Ccycle), 1630 (amide), 1599 (Ph), 1520 (NH); 1H-NMR (DMSO-d6) δ: 7.41 (d, J=8.5 Hz, 1H), 7.70 (d, J=9.1 Hz, 2H), 7.90 (d, J=9.1 Hz, 2H), 8.15 (d, J=8.5 Hz, 1H), 8.50 (s, 1H), 12.40 (s, 1H), 12.95 (s, 1H), 16 (s, 1H).
3-(4-Carboxy-3-hydroxyphenylcarbamoyl)-4-hydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic acid (12). 4-Aminosalicylic acid (0.7 g, 0.005 mol) was mixed with triethyl methanetricarboxylate (2.12 mL, 0.01 mol) and heated in microwave reactor at 50% of power for 15 min and 3 min at 90%. The temperature reached 230 °C during heating. Et2O was added to the cooled mixture and the precipitate was washed with hot (55 °C) MeOH to obtain the pure product as a yellow crystalline compound. Yield 20%; Mp 350 °C; Anal. calc. for C18H12N2O9 (400.29): C 54.01%, H 3.02%; found: C 54.05%, H 9.94%; HPLC purity 96.42%; UV (nm), λmax/log ε: 256.0/3.53; IR (cm-1): 3620, 1179 (OH), 3035 (CHarom), 2972, 1688 (acid), 1680 (lactam), 1640 (C=O), 1633 (C=Ccycle), 1632 (amide), 1600 (Ph), 1521 (NH), 1329, 1199 (OHphenol); 1H-NMR (DMSO-d6) δ: 7.43 (d, J=8.5 Hz, 2H), 7.7 (s, 1H), 7.9 (m, 3H), 10.43 (s, 1H), 10.47 (s, 1H), 12.7 (s, 1H) 16.0 (s, 1H).

4.2. Lipophilicity HPLC determination (capacity factor k / calculated log k)

The HPLC separation module Waters Alliance 2695 XE and Waters Photodiode Array Detector 2996 (Waters Corp., Milford, MA, U.S.A.) were used. A Symmetry® C18 5 μm, 4.6 × 250 mm, Part No. WAT054275, (Waters Corp., Milford, MA, U.S.A.) chromatographic column was used. The HPLC separation process was monitored by Millennium32® Chromatography Manager Software, Waters 2004 (Waters Corp., Milford, MA, U.S.A.). The mixture of MeOH p.a. (55.0%) and H2O-HPLC – Mili-Q Grade (45.0%) was used as a mobile phase. The total flow of the column was 0.9 mL/min, injection 30 μL, column temperature 30 °C and sample temperature 10 °C. The detection wavelength 210 nm was chosen. The KI methanolic solution was used for the dead time (TD) determination. Retention times (tR) were measured in minutes. The capacity factors k were calculated using the Millennium32® Chromatography Manager Software according to formula k = (tR - tD) / tD, where tR is the retention time of the solute, whereas tD denotes the dead time obtained via an unretained analyte. Log k, calculated from the capacity factor k, is used as the lipophilicity index converted to log P scale. The log k values of the individual compounds are shown in Table 1.

4.3. Lipophilicity calculations

Log P, i.e. the logarithm of the partition coefficient for n-octanol/water, was calculated using the programs CS ChemOffice Ultra ver. 9.0 (CambridgeSoft, Cambridge, MA, U.S.A.) and ACD/LogP ver. 1.0 (Advanced Chemistry Development Inc., Toronto, Canada). Clog P values (the logarithm of n-octanol/water partition coefficient based on established chemical interactions) were generated by means of CS ChemOffice Ultra ver. 9.0 (CambridgeSoft, Cambridge, MA, U.S.A.) software. The results are shown in Table 1.

4.4. Study of inhibition of oxygen evolution rate (OER) in spinach chloroplasts

Chloroplasts were prepared from spinach (Spinacia oleracea L.) according to Masarovicova and Kralova [36]. The inhibition of photosynthetic electron transport (PET) in spinach chloroplasts was determined spectrophotometrically (Genesys 6, Thermo Scientific, U.S.A.) using an artificial electron acceptor 2,6-dichlorophenol-indophenol (DCPIP) according to Kralova et al. [37] and the rate of photosynthetic electron transport was monitored as a photoreduction of DCPIP. The measurements were carried out in phosphate buffer (0.02 mol/L, pH 7.2) containing sucrose (0.4 mol/L), MgCl2 (0.005 mol/L) and NaCl (0.015 mol/L). The chlorophyll content was 30 mg/L in these experiments and the samples were irradiated (~100 W/m2) from 10 cm distance with a halogen lamp (250 W) using a 4 cm water filter to prevent warming of the samples (suspension temperature 22 °C). The studied compounds were dissolved in DMSO due to their limited water solubility. The applied DMSO concentration (up to 4%) did not affect the photochemical activity in spinach chloroplasts. The inhibitory efficiency of the studied compounds was expressed by IC50 values, i.e. by molar concentration of the compounds causing 50% decrease in the oxygen evolution rate relative to the untreated control. The comparable IC50 value for a selective herbicide 3-(3,4-dichlorophenyl)-1,1-dimethylurea, DCMU (Diurone®) was about 1.9 μmol/L [38]. The results are summarized in Table 2.

4.4. In vitro antifungal susceptibility testing

The broth microdilution test [27,39] was used for the assessment of in vitro antifungal activity of the synthesized compounds against Candida albicans ATCC 44859 (CA), Candida tropicalis 156 (CT), Candida krusei ATCC 6258 (CK), Candida glabrata 20/I (CG), Trichosporon beigelii 1188 (TB), Aspergillus fumigatus 231 (AF), Absidia corymbifera 272 (AC), and Trichophyton mentagrophytes 445 (TM). Fluconazole (FLU) was used as the standard of a clinically used antimycotic drug. The procedure was performed with twofold dilution of the compounds in RPMI 1640 (Sevapharma a.s., Prague, Czech Republic) buffered to pH 7.0 with 0.165 mol of 3-morpholino-propane-1-sulfonic acid (MOPS, Sigma, Germany). The final concentrations of the compounds ranged from 500 to 0.975 μmol/l. Drug–free controls were included. The MIC was defined as an 80% or greater (IC80) reduction of growth in comparison with the control. The values of MICs were determined after 24 and 48 h of static incubation at 35 °C. For T. mentagrophytes, the final MICs were determined after 72 and 120 h of incubation. The results are summarized in Table 2.

Acknowledgements

This study was supported by the Polish Ministry of Science N405 178735, by the Ministry of Education of the Czech Republic MSM 6215712403, by the Slovak Scientific Grant Agency VEGA 1/0089/03, and by the Irish Department of Education and Science TSR Strand1-06/CR08.

References

  1. Roth, H.J.; Fenner, H. Arzneistoffe, 3rd Ed. ed; Deutscher Apotheker Verlag: Stuttgart, Germany, 2000; pp. 51–114. [Google Scholar]
  2. Polanski, J.; Niedbala, H.; Musiol, R.; Podeszwa, B.; Tabak, D.; Palka, A.; Mencel, A.; Finster, J.; Mouscadet, J.F.; Le Bret, M. 5-Hydroxy-8-nitro-6-quinaldic Acid as a Novel Molecular Scaffold for HIV-1 Integrase Inhibitors. Lett. Drugs Des. Disc. 2006, 3, 175–178. [Google Scholar] [CrossRef]
  3. Polanski, J.; Niedbala, H.; Musiol, R.; Podeszwa, B.; Tabak, D.; Palka, A.; Mencel, A.; Mouscadet, J.F.; Le Bret, M. Fragment Based Approach for the Investigation of HIV-1 Integrase Inhibition. Lett. Drugs Des. Disc. 2007, 4, 99–105. [Google Scholar] [CrossRef]
  4. Vargas, L.Y.; Castelli, M.V.; Kouznetsov, V.V.; Urbina, J.M.; Lopez, S.N.; Sortino, M.; Enriz, R.D.; Ribas, J.C.; Zacchino, S. In vitro Antifungal Activity of New Series of Homoallylamines and Related Compounds with Inhibitory Properties of the Synthesis of Fungal Cell Wall Polymers. Bioorg. Med. Chem. 2003, 11, 1531–1550. [Google Scholar] [CrossRef]
  5. Jampilek, J.; Dolezal, M.; Kunes, J.; Buchta, V. Quinaldine derivatives preparation and their antifungal activity. ECSOC-8. 2004, p. c005. Available online: http://www.lugo.usc.es/%7Eqoseijas/ECSOC-8/BOCNP/005/index.htm.
  6. Jampilek, J.; Dolezal, M.; Kunes, J.; Buchta, V.; Kralova, K. Quinaldine Derivatives: Preparation and Biological Activity. Med. Chem. 2005, 1, 591–599. [Google Scholar] [CrossRef]
  7. Musiol, R.; Jampilek, J.; Buchta, V.; Niedbala, H.; Podeszwa, B.; Palka, A.; Majerz-Maniecka, K.; Oleksyn, B.; Polanski, J. Antifungal Properties of New Series of Quinoline Derivatives. Bioorg. Med. Chem. 2006, 14, 3592–3598. [Google Scholar] [CrossRef]
  8. Musiol, R.; Jampilek, J.; Kralova, K.; Podeszwa, B.; Finster, J.; Niedbala, H.; Palka, A.; Polanski, J. New quinoline derivatives possessing herbicidal activity. ECSOC-9. 2005, p. c005. Available online: http://www.usc.es/congresos/ecsoc/9/BOCNP/c005/index.htm.
  9. Musiol, R.; Jampilek, J.; Kralova, K.; Tabak, D.; Podeszwa, B.; Finster, J.; Polanski, J. Substituted amides of quinoline derivatives: preparation and their photosynthesis-inhibiting activity. ECSOC-10. 2006, p. c007. Available online: http://www.usc.es/congresos/ecsoc/10/ECSOC10.htm.
  10. Musiol, R.; Jampilek, J.; Kralova, K.; Richardson, D.R.; Kalinowski, D.; Podeszwa, B.; Finster, J.; Niedbala, H.; Palka, A.; Polanski, J. Investigating Biological Activity Spectrum for Novel Quinoline Analogues. Bioorg. Med. Chem. 2007, 15, 1280–1288. [Google Scholar] [CrossRef]
  11. Musiol, R.; Jampilek, J.; Kralova, K.; Tabak, D.; Finster, J.; Podeszwa, B.; Kozik, V.; Dohnal, J.; Polanski, J. Preparation and Herbicidal Activities of Substituted Amides of Quinoline Derivatives. ECSOC-11. 2007, p. a011. Available online: http://www.usc.es/congresos/ecsoc/11/hall_aGOS/a011/index.htm.
  12. Musiol, R.; Tabak, D.; Niedbala, H.; Podeszwa, B.; Jampilek, J.; Kralova, K.; Dohnal, J.; Finster, J.; Mencel, A.; Polanski, J. Investigating Biological Activity Spectrum for Novel Quinoline Analogues 2: Hydroxyquinolinecarboxamides with Photosynthesis Inhibiting Activity. Bioorg. Med. Chem. 2008, 16, 4490–4499. [Google Scholar] [CrossRef]
  13. Musiol, R.; Jampilek, J.; Kralova, K.; Finster, J.; Tabak, D.; Niedbala, H.; Csollei, J.; Dohnal, J.; Polanski, J. Ring-substituted 4-hydroxy-1H-quinolin-2-ones: Preparation and Their Photosynthesis-inhibiting Activity. ECSOC-12. 2008, p. c0012. Available online: http://www.usc.es/congresos/ecsoc/12/ECSOC12.htm.
  14. Podeszwa, B.; Niedbala, H.; Polanski, J.; Musiol, R.; Tabak, D.; Finster, J.; Serafin, K.; Wietrzyk, J.; Boryczka, S.; Mol, W.; Jampilek, J.; Dohnal, J.; Kalinowski, D.; Richardson, D.R. Investigating the Antiproliferative Activity of Quinoline-5,8-dione Analogues on Tumour Cell Lines. Bioorg. Med. Chem. Lett. 2007, 17, 6138–6141. [Google Scholar] [CrossRef]
  15. Reifler, M.J.; Szalai, V.A.; Peterson, C.N.; Brudvig, G.W. Effects of Tail-like Substituents on the Binding of Competitive Inhibitors to the QB Site of Photosystem II. J. Mol. Recognit. 2001, 14, 157–165. [Google Scholar]
  16. Moreland, D.E. Research on Biochemistry of Herbicides – an Historical Overview. Z. Naturforsch. C-A J. Biosci. 1993, 48, 121–131. [Google Scholar]
  17. Zakarya, D.; Larfaoui, E.M.; Boulaamail, A.; Tollabi, M.; Lakhlifi, T. QSARs for a Series of Inhibitory Anilides. Chemosphere 1998, 36, 2809–2818. [Google Scholar] [CrossRef]
  18. Kralova, K.; Sersen, F.; Kubicova, L.; Waisser, K. Inhibitory Effects of Substituted Benzanilides on Photosynthetic Electron Transport in Spinach Chloroplasts. Chem. Pap. 1999, 53, 328–331. [Google Scholar]
  19. Dolezal, M.; Miletin, M.; Kunes, J.; Kralova, K. Synthesis and Biological Evaluation of Some Amides of Pyrazine-2-carboxylic acids. Molecules 2002, 7, 363–373. [Google Scholar] [CrossRef]
  20. Dolezal, M.; Palek, L.; Vinsova, J.; Buchta, V.; Jampilek, J.; Kralova, K. Substituted Pyrazinecarboxamides: Synthesis And Biological Evaluation. Molecules 2006, 11, 242–256. [Google Scholar] [CrossRef]
  21. Dolezal, M.; Cmedlova, P.; Palek, L.; Vinsova, J.; Kunes, J.; Buchta, V.; Jampilek, J.; Kralova, K. Synthesis and Antimycobacterial Evaluation of Substituted Pyrazinecarboxamides. Eur. J. Med. Chem. 2008, 43, 1105–1113. [Google Scholar]
  22. Polak, A. The past, Present and Future of Antimycotic Combination Therapy. Mycoses 1999, 42, 355–370. [Google Scholar] [CrossRef]
  23. Fostel, J.M.; Lartey, P.A. Emerging Novel Antifungal Agents. Drug Discov. Today 2000, 5, 25–32. [Google Scholar] [CrossRef]
  24. Available online: http://www.doctorfungus.org/ accessed on January 30, 2009.
  25. Gershon, H; Gershon, M; Clarke, D.D. Synergistic Mixtures of Fungitoxic Monochloro- and Dichloro-8-quinolinols against Five Fungi. Mycopathologia 2004, 158, 131–135. [Google Scholar] [CrossRef]
  26. Dardari, Z.; Lemrani, M.; Bahloul, A.; Sebban, A.; Hassar, M.; Kitane, S.; Berrada, M.; Boudouma, M. Antileishmanial Activity of a New 8-Hydroxyquinoline Derivative Designed 7-[5′-(3′-phenylisoxazolino)methyl]-8-hydroxyquinoline: preliminary study. Farmaco 2004, 59, 195–199. [Google Scholar] [CrossRef]
  27. Sheehan, D.J.; Espinel-Ingroff, A.; Steele, M.; Webb, C.D. Antifungal Susceptibility Testing of Yeasts: a Brief Overview. Clin. Infect. Dis. 1993, 17, 494–500. [Google Scholar] [CrossRef]
  28. Dolezal, M.; Jampilek, J.; Osicka, Z.; Kunes, J.; Buchta, V.; Vichova, P. Substituted 5-aroylpyrazine-2-carboxylic Acid Derivatives: Synthesis and Biological Activity. Farmaco 2003, 58, 1105–1111. [Google Scholar] [CrossRef]
  29. Collins, J.F.; Donnelly, W.J.; Grundon, M.F.; James, K.J. Biosynthesis of Aromatic Isoprenoids. Part I. The role of 3-Prenylquinolines and of Platydesmine in the Biosnthesis of the Furuquinoline Alkaloid, Dictamnine. J. Chem. Soc., Perkin Trans. 1974, 1, 2177–2181. [Google Scholar]
  30. Buckle, D.R.; Cantello, B.C.C.; Smith, H.; Spicer, B.A. 4-Hydroxy-3-nitro-2-quinolones and Related Compounds as Inhibitors of Allergic Reactions. J. Med. Chem. 1975, 18, 726–732. [Google Scholar] [CrossRef]
  31. Ziegler, E.; Wolf, R.; Kappe, T. Synthesen von Heterocyclen, 66. Mitt.: Eine Einfache Synthese des 4-Hydroxycarbostyrils und seiner Derivate. Monatsh. Chem. 1965, 96, 418–422. [Google Scholar] [CrossRef]
  32. Dolle, V.; Fan, E.; Nguyen, C.H.; Aubertin, A.M.; Kirn, A.; Andreola, M.L.; Jamieson, G.; Tarrago-Litvak, L.; Bisagni, E. A New Series of Pyridinone Derivatives as Potent non-Nucleoside Human Immunodeficiency Virus Type 1 Specific Reverse Transcriptase Inhibitors. J. Med. Chem. 1995, 38, 4679–4686. [Google Scholar] [CrossRef]
  33. Ukrainets, I.V.; Taran, S.G.; Sidorenko, L.V.; Gorokhova, O.V.; Ogirenko, A.A.; Turov, A.V.; Filimonova, N.I. 4-Hydroxy-2-quinolones. 3-Amino-1-R-2-oxo-4-hydroxyquinolines and Their Acyl Derivatives. Chem. Heterocycl.Compd. 1996, 32, 960–970. [Google Scholar] [CrossRef]
  34. Ukrainets, I.V.; Gorokhova, O.V.; Sidorenko, L.V. 4-Hydroxyquinol-2-ones. 85. Synthesis of 2-Chloro-4-hydroxyquinoline-3-carboxylic Acid Ethyl Ester. Chem. Heterocycl. Compd. 2005, 41, 1019–1021. [Google Scholar] [CrossRef]
  35. Detsi, A.; Bardakos, V.; Markopoulos, J.; Igglessi-Markopoulou, O. Reactions of 2-Methyl-3,1-benzoxazin-4-one with Active Methylene Compounds: a New Route to 3-Substituted 4-Hydroxyquinolin-2(1H)-ones. J. Chem. Soc., Perkin Trans. 1 1996, 24, 2909–2913. [Google Scholar]
  36. Masarovicova, E.; Kralova, K. Approaches to Measuring Plant Photosynthesis Activity. In Handbook of Photosynthesis, 2nd Ed.; Pessarakli, M., Ed.; Taylor & Francis Group: Boca Raton, London-New York-Singapore, 2005; pp. 617–656. [Google Scholar]
  37. Kralova, K.; Sersen, F.; Sidoova, E. Photosynthesis Inhibition Produced by 2-Alkylthio-6-R-benzothiazoles. Chem. Pap. 1992, 46, 348–350. [Google Scholar]
  38. Fedke, C. Biochemistry and Physiology of Herbicide Action.; Springer Verlag: Berlin-Heidelberg-New York, USA , 1982. [Google Scholar]
  39. National Committee for Clinical Laboratory standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast: Approved Standard, NCCLS document M27-A; NCCLS: Villanova, PA, USA, 1997. [Google Scholar]
  • Sample Availability: Samples of the compounds are available from the authors.

Share and Cite

MDPI and ACS Style

Jampilek, J.; Musiol, R.; Pesko, M.; Kralova, K.; Vejsova, M.; Carroll, J.; Coffey, A.; Finster, J.; Tabak, D.; Niedbala, H.; et al. Ring-substituted 4-Hydroxy-1H-quinolin-2-ones: Preparation and Biological Activity. Molecules 2009, 14, 1145-1159. https://doi.org/10.3390/molecules14031145

AMA Style

Jampilek J, Musiol R, Pesko M, Kralova K, Vejsova M, Carroll J, Coffey A, Finster J, Tabak D, Niedbala H, et al. Ring-substituted 4-Hydroxy-1H-quinolin-2-ones: Preparation and Biological Activity. Molecules. 2009; 14(3):1145-1159. https://doi.org/10.3390/molecules14031145

Chicago/Turabian Style

Jampilek, Josef, Robert Musiol, Matus Pesko, Katarina Kralova, Marcela Vejsova, James Carroll, Aidan Coffey, Jacek Finster, Dominik Tabak, Halina Niedbala, and et al. 2009. "Ring-substituted 4-Hydroxy-1H-quinolin-2-ones: Preparation and Biological Activity" Molecules 14, no. 3: 1145-1159. https://doi.org/10.3390/molecules14031145

APA Style

Jampilek, J., Musiol, R., Pesko, M., Kralova, K., Vejsova, M., Carroll, J., Coffey, A., Finster, J., Tabak, D., Niedbala, H., Kozik, V., Polanski, J., Csollei, J., & Dohnal, J. (2009). Ring-substituted 4-Hydroxy-1H-quinolin-2-ones: Preparation and Biological Activity. Molecules, 14(3), 1145-1159. https://doi.org/10.3390/molecules14031145

Article Metrics

Back to TopTop